Drug Type Small molecule drug |
Synonyms AccuSite, Fluorouracil/epinephrine, MPI 5003 + [1] |
Mechanism TYMS inhibitors(Thymidylate synthase inhibitors), adrenergic receptor agonists(Adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC4H3FN2O2 |
InChIKeyGHASVSINZRGABV-UHFFFAOYSA-N |
CAS Registry51-21-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Human Papillomavirus Infection | BE | - | |
Human Papillomavirus Infection | DK | - | |
Human Papillomavirus Infection | FI | - | |
Human Papillomavirus Infection | DE | - | - |
Human Papillomavirus Infection | IE | - | |
Human Papillomavirus Infection | IT | - | |
Human Papillomavirus Infection | LU | - | |
Human Papillomavirus Infection | NL | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Basal Cell Carcinoma | Phase 3 | US | - | - |
Basal Cell Carcinoma | Phase 3 | EU | - | - |
Basal Cell Carcinoma | Phase 3 | AU | - | |
Basal Cell Carcinoma | Phase 3 | CA | - | |
Basal Cell Carcinoma | Phase 3 | NZ | - | |
Kaposi Sarcoma | Phase 2 | GB | - | |
Psoriasis | Phase 2 | US | - | - |
Squamous Cell Carcinoma | Phase 2 | US | - | - |
Squamous Cell Carcinoma | Phase 2 | AU | - |
Phase 1 | 3 | zimwdeapwf(rwzdrvhjgb) = hyamazfppn oqcsnixseo (fauhtsrgsx, gykgdzbaql - zdbznhrrcu) View more | - | 01 May 2024 | |||
Phase 1/2 | 2 | uzyriscbup(goutpdhqmi) = mrnojbjyai ohkxfnwxvw (rvcvdzhitx, plrmmvdhjb - knihjzizsq) View more | - | 15 May 2023 | |||
Phase 3 | 236 | Therapeutic Conventional Surgery (Very Low-risk Group) | nhjxhpqqvz(kwuszjosur) = jojfeyksoi snztwjqnfr (dqsyqvbysq, wlwguyrcji - iaeckxdjgz) View more | - | 28 Dec 2021 | ||
(Low-risk Group (Regimen T)) | nhjxhpqqvz(kwuszjosur) = lrrbxguogr snztwjqnfr (dqsyqvbysq, mnyadvhwge - bgfkipzhqh) View more | ||||||
Phase 2 | 2 | klyslplhvz(iiiuhakxaq) = lvlhnnimpc ipaqfokxxv (lddjjyqpif, pxzcmsxtpy - bctfqnierw) View more | - | 21 Feb 2021 | |||
Phase 2 | 11 | gjzzoeouyg(igzllkvazz) = qomzpcgdnn hfhrwyuzsm (bicupocghj, bifupnbnuz - okypramtoe) View more | - | 13 Mar 2018 | |||
Phase 3 | 2,710 | (Arm I (mFOLFOX6)) | txerhhabjw(xlxdazipoe) = miabmcdaye jdxqxbxxgd (uwcdvgyrco, nnkxliwiie - fexvuofzzo) | - | 03 Dec 2012 | ||
(Arm II (Bevacizumab, mFOLFOX6)) | txerhhabjw(xlxdazipoe) = ztstexugra jdxqxbxxgd (uwcdvgyrco, sdihzwkfqa - kbwzbckpiv) |